Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELND005 in Young Adults With Down Syndrome
NCT01791725Phase 2Completed
- Sponsor
- OPKO Health
- Start
- Sep 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of scyllo-inositol in Down syndrome, sponsored by OPKO Health. Started Sep 2013; status: completed.
02
Drugs
scyllo-inositol
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT01791725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791725.